Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MCServicesAG
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MCServicesAG
-
#IAmAndIWill
with #VAXIMM and its partner@NEC. The two companies have a strategic collaboration to co-develop personalized#neonatigen#cancervaccines, which will be evaluated in a Phase I clinical trial in various#solidtumors. https://bit.ly/31398Jc#WorldCancerDay
pic.twitter.com/9VmYKvRMGG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is
#WorldCancerDay
! Cancer is the 2nd leading cause of death worldwide. Many companies, including some of our clients, #VAXIMM,#Xenikos,@MagForce_AG,@MorphoSys and@HeidelbergPharm, are developing cutting-edge anti-tumor treatments to win the battle against cancer.pic.twitter.com/5UCC5swk2a
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
Today is
#WorldCancerDay2020
.
We are fueled by our mission to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. #cancer#IAmAndIWill
#DLBCL#CancerAwareness#antibodypic.twitter.com/Wi09VvoMUU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is
#WorldCancerDay
’s 20th anniversary - @HeidelbergPharm uses the power of#Amanitin from the death cap mushroom for the development of Antibody Targeted#Amanitin Conjugates (#ATACs) against#cancer.#IAmAndIWill
Read more
http://goo.gl/YwiD82 pic.twitter.com/Fih03jPKZe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On
#WorldCancerDay
we recognize cancer treatment requires innovation. Our client @MagForce_AG is a pioneer in the field using#nanotechnology to fight cancer from within.#braintumors#prostratecancer – learn more about their#NanoTherm therapy system here https://bit.ly/31jq7Y0 pic.twitter.com/8YTSlGaBPK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
February 4th is
#WorldCancerDay
. 20 years ago, 6 cancer experts established this day to acknowledge the impact of cancer and build an alliance against “fear, ignorance and complacency” - #IAmAndIWill
together with #VAXIMM,#Xenikos,@MagForce_AG@MorphoSys and@HeidelbergPharmpic.twitter.com/dP3VgrqWLU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Xenikos will make an impact to create a future without cancer with its immunotherapy T-Guard currently in Ph 3 trial in the U.S. to treat SR-aGVHD in blood cancer patients following an allogeneic stem cell transplant.#WorldCancerDay
, #IAmAndIWill
pic.twitter.com/4djy8Bixk7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is
#WorldCancerDay
- #IAmAndIWill
with #VAXIMM! Its lead candidate#VXM01 is advancing in clinical development and targeting different important#cancer indications like#glioblastoma and metastatic#colorectalcancer. Discover more
http://goo.gl/db9mtN pic.twitter.com/88Ubj2fSW7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
#WorldCancerDay
: @MagForce_AG has cooperated with the Paracelsus Clinic in Zwickau since last year. Prof. Dr. Warnke is now successfully treating patients with our NanoTherm therapy system.https://bit.ly/2GSViQyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
20 years ago,
#WorldCancerDay
was established to acknowledge the impact of cancer on human life and society. Aiming to fight #Cancer, MorphoSys is developing#immunooncology therapies#IAmAndIWill
#antibody#CancerAwareness#DLBCL#leukemiapic.twitter.com/TiN1hvX5bE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today is
#WorldCancerDay
– #IAmAndIWill
with @HeidelbergPharm’s Antibody Targeted#Amanitin Conjugate (#ATAC) technology designed to fight#cancer -> the#BCMA-ATAC#HDP-101 against#multiplemyeloma. Discover More
http://goo.gl/YwiD82 pic.twitter.com/lUwFoqhtGw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
German CDMO Forms Smart U.S. Subsidiary: In the pharmaceutical industry many products have been launched using wellestablished processes. But if new products are to reach greater heights these processes must be improved. Whats needed is the boost that…http://bioportfol.io/RP9vxw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
Knowledge and science have no borders. Scientists and experts of all World are working together to find a solution to beat
#2019nCoV. German scientists are also contributing by working and sharing results.#UnityIsStrength#coronaviruspic.twitter.com/aaynqWz8gG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
As the
#coronavirus spreads, fear is fueling racism and#xenophobia - CNN. This is not the they. We need to fight#together and not against each other.https://www.cnn.com/2020/01/31/asia/wuhan-coronavirus-racism-fear-intl-hnk/index.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@GBAGroupPharma Highlights Looming Clinical Trial Issues for Biotech and Pharma Companies Post UK Departure from The EU#Brexit#BrexitDay https://www.gba-group.de/en/divisions/gba-pharma/your-brexit-solution-with-gba-group-pharma/ …pic.twitter.com/TQgrjTvuXE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Next week is
#WorldCancerDay
- Read how @HeidelbergPharm and@MagentaTx partnered up to develop Antibody Targeted Amanitin Conjugates (#ATAC) for targeted#conditioning of#cancer patients. Discover more
https://bit.ly/2U8do8P pic.twitter.com/8eLbiv7eus
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Next week is
#WorldCancerDay
- #VAXIMM is developing innovative oral T-cell#immunotherapies for patients suffering from#cancer by targeting cancer-related antigens. Discover more about its lead candidate#VXM01 and pipeline
http://goo.gl/db9mtN #IAmAndIWill
pic.twitter.com/nC2rNd2dDX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#VAXIMM to Participateat Upcoming Industry Events https://vaximm.com/wp-content/uploads/2020/01/20200130_VAXIMM_PR_Upcoming-Events_ENG.pdf …@EBDgroup@IAmBiotech@SachsAssociatespic.twitter.com/nEta56sXIT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany http://bit.ly/36B3wY6
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MC Services AG proslijedio/la je Tweet
The world is under virus attack, but German scientists are already on the move.
@Tagesspiegel spoke with Prof. Dr. Ludwig, developer of@AtrivaTx’ host-targeting#antiviral candidate,#ATR002, about pandemic threats like#flu, SARS, MERS and#coronavirus. https://bit.ly/2O7CMrK pic.twitter.com/fT8OSsdVdv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.